Contrasting studies report TNF-alpha as anti-tumoural (cytotoxic or cytostatic) or pro-tumoural for medulloblastoma, and that both TNF-alpha transgene and TNFR antagonist treatment portray favourable outcomes in xenograft models44–46. Here, TNFRSF1A is linked to medulloblastoma.